Moreover, treatment with AKT or ERK inhibitors showed that upregulation of phospho-GSK-3β and phospho-FOXO1 was significantly attenuated in GNA13-overexpressed GC cells, along with significant suppression of cellular growth and colony formation. The gene discussed is GNA13; the disease is gastric cancer.